1. 1) Novartis Pharmaceuticals Co., Ltd., 2009, “Sandostatin® for s.c. injection: Prescribing Information,”: ‹http://product.novartis.co.jp/sas/pi/pi_sas.pdf›, cited 24 Aug. 2013
2. 2) Novartis Pharmaceuticals Co., Ltd., 2009, “Sandostatin® for s.c. injection: Interview Form,”: ‹http://product.novartis.co.jp/sas/if/if_sas.pdf›, cited 24 Aug. 2013
3. 3) Novartis Pharmaceuticals Co., Ltd., 2013, “Sandostatin® for s.c. injection: Sandostatin® Prescribing Information,”: ‹http://www.pharma.us.novartis.com/cs/www.pharma.us.novartis.com/product/pi/pdf/sandostatin_inj.pdf›, cited 24 Aug. 2013
4. 4) Tanimura K., Onda S., Mitsunobu M., Gan To Kagaku Ryoho, 37, 1991–1993 (2010).
5. 5) Shima Y., Ohtsu A., Shirao K., Sasaki Y., Jpn. J. Clin. Oncol., 38, 354–359 (2008).